Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anti-asialo-GM1 antibody
- Development stage
- Unknown
- Lead developer
- BioLegend
- Modality
- Antibody-Based Therapeutics
- Administration
- Intperitoneal, Intravenous
01
Overview
Anti-asialo-GM1 antibody is a rabbit polyclonal antibody that targets the neutral glycosphingolipid asialo-GM1 (gangliotetraosylceramide), which is highly expressed on the surface of natural killer (NK) cells, as well as other immune cells such as basophils, NKT cells, and subsets of T cells. It is widely used as a research-use-only (RUO) laboratory reagent to selectively deplete conventional NK cells in vivo in animal models (such as mice and rats) to study the role of NK cells in tumor metastasis, viral infections, and immune responses. The antibody is commercially produced by vendors such as Fujifilm Wako Pure Chemical and BioLegend.
- Other names
- anti-AsGM1 antibodyanti-AsGM-1 antibodyanti-AsGM 1 antibodyanti-asialo GM1anti-asialo-GM1anti-asialo-GM-1anti-asialo-GM 1anti-asialo-ganglio-N-tetraosylceramide antibodyrabbit anti-asialo-GM1
02
Targets
Sphingolipid (Sphingolipid metabolism)
Beyond the preview
Go deeper on anti-asialo-GM1 antibody.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anti-asialo-GM1 antibody.